These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 17494865

  • 1. Distinct Ca2+ requirement for NO production between proteinase-activated receptor 1 and 4 (PAR1 and PAR4) in vascular endothelial cells.
    Hirano K, Nomoto N, Hirano M, Momota F, Hanada A, Kanaide H.
    J Pharmacol Exp Ther; 2007 Aug; 322(2):668-77. PubMed ID: 17494865
    [Abstract] [Full Text] [Related]

  • 2. Immediate and delayed VEGF-mediated NO synthesis in endothelial cells: role of PI3K, PKC and PLC pathways.
    Gélinas DS, Bernatchez PN, Rollin S, Bazan NG, Sirois MG.
    Br J Pharmacol; 2002 Dec; 137(7):1021-30. PubMed ID: 12429574
    [Abstract] [Full Text] [Related]

  • 3. P2Y2 receptor-Gq/11 signaling at lipid rafts is required for UTP-induced cell migration in NG 108-15 cells.
    Ando K, Obara Y, Sugama J, Kotani A, Koike N, Ohkubo S, Nakahata N.
    J Pharmacol Exp Ther; 2010 Sep 01; 334(3):809-19. PubMed ID: 20511347
    [Abstract] [Full Text] [Related]

  • 4. Carbon monoxide releasing molecule induces endothelial nitric oxide synthase activation through a calcium and phosphatidylinositol 3-kinase/Akt mechanism.
    Yang PM, Huang YT, Zhang YQ, Hsieh CW, Wung BS.
    Vascul Pharmacol; 2016 Dec 01; 87():209-218. PubMed ID: 27720892
    [Abstract] [Full Text] [Related]

  • 5. Reconstituted high-density lipoprotein inhibits thrombin-induced endothelial tissue factor expression through inhibition of RhoA and stimulation of phosphatidylinositol 3-kinase but not Akt/endothelial nitric oxide synthase.
    Viswambharan H, Ming XF, Zhu S, Hubsch A, Lerch P, Vergères G, Rusconi S, Yang Z.
    Circ Res; 2004 Apr 16; 94(7):918-25. PubMed ID: 14988229
    [Abstract] [Full Text] [Related]

  • 6. Featured Article: Differential regulation of endothelial nitric oxide synthase phosphorylation by protease-activated receptors in adult human endothelial cells.
    Tillery LC, Epperson TA, Eguchi S, Motley ED.
    Exp Biol Med (Maywood); 2016 Mar 16; 241(6):569-80. PubMed ID: 26729042
    [Abstract] [Full Text] [Related]

  • 7. Involvement of Gi/o in the PAR-4-induced NO production in endothelial cells.
    Momota F, Hirano K, Hirano M, Nishimura J, Kanaide H.
    Biochem Biophys Res Commun; 2006 Apr 07; 342(2):365-71. PubMed ID: 16483540
    [Abstract] [Full Text] [Related]

  • 8. Functional selectivity of G protein signaling by agonist peptides and thrombin for the protease-activated receptor-1.
    McLaughlin JN, Shen L, Holinstat M, Brooks JD, Dibenedetto E, Hamm HE.
    J Biol Chem; 2005 Jul 01; 280(26):25048-59. PubMed ID: 15878870
    [Abstract] [Full Text] [Related]

  • 9. Role of protease-activated receptor-1 in endothelial nitric oxide synthase-Thr495 phosphorylation.
    Watts VL, Motley ED.
    Exp Biol Med (Maywood); 2009 Feb 01; 234(2):132-9. PubMed ID: 19064940
    [Abstract] [Full Text] [Related]

  • 10. Endothelial thrombomodulin induces Ca2+ signals and nitric oxide synthesis through epidermal growth factor receptor kinase and calmodulin kinase II.
    David-Dufilho M, Millanvoye-Van Brussel E, Topal G, Walch L, Brunet A, Rendu F.
    J Biol Chem; 2005 Oct 28; 280(43):35999-6006. PubMed ID: 16126727
    [Abstract] [Full Text] [Related]

  • 11. Early activation of the p42/p44MAPK pathway mediates adenosine-induced nitric oxide production in human endothelial cells: a novel calcium-insensitive mechanism.
    Wyatt AW, Steinert JR, Wheeler-Jones CP, Morgan AJ, Sugden D, Pearson JD, Sobrevia L, Mann GE.
    FASEB J; 2002 Oct 28; 16(12):1584-94. PubMed ID: 12374781
    [Abstract] [Full Text] [Related]

  • 12. Pregnancy-enhanced endothelial nitric oxide synthase (eNOS) activation in uterine artery endothelial cells shows altered sensitivity to Ca2+, U0126, and wortmannin but not LY294002--evidence that pregnancy adaptation of eNOS activation occurs at multiple levels of cell signaling.
    Sullivan JA, Grummer MA, Yi FX, Bird IM.
    Endocrinology; 2006 May 28; 147(5):2442-57. PubMed ID: 16455784
    [Abstract] [Full Text] [Related]

  • 13. High glucose-induced apoptosis in human vascular endothelial cells is mediated through NF-kappaB and c-Jun NH2-terminal kinase pathway and prevented by PI3K/Akt/eNOS pathway.
    Ho FM, Lin WW, Chen BC, Chao CM, Yang CR, Lin LY, Lai CC, Liu SH, Liau CS.
    Cell Signal; 2006 Mar 28; 18(3):391-9. PubMed ID: 15970429
    [Abstract] [Full Text] [Related]

  • 14. The ATP-gated P2X1 receptor plays a pivotal role in activation of aspirin-treated platelets by thrombin and epinephrine.
    Grenegård M, Vretenbrant-Oberg K, Nylander M, Désilets S, Lindström EG, Larsson A, Ramström I, Ramström S, Lindahl TL.
    J Biol Chem; 2008 Jul 04; 283(27):18493-504. PubMed ID: 18480058
    [Abstract] [Full Text] [Related]

  • 15. Signaling mechanisms involved in protease-activated receptor-1-mediated interleukin-6 production by human gingival fibroblasts.
    Tanaka N, Morita T, Nezu A, Tanimura A, Mizoguchi I, Tojyo Y.
    J Pharmacol Exp Ther; 2004 Nov 04; 311(2):778-86. PubMed ID: 15210834
    [Abstract] [Full Text] [Related]

  • 16. Bi-phasic activation of eNOS in response to uni-axial cyclic stretch is mediated by differential mechanisms in BAECs.
    Takeda H, Komori K, Nishikimi N, Nimura Y, Sokabe M, Naruse K.
    Life Sci; 2006 Jun 13; 79(3):233-9. PubMed ID: 16458937
    [Abstract] [Full Text] [Related]

  • 17. Insulin-stimulated activation of eNOS is independent of Ca2+ but requires phosphorylation by Akt at Ser(1179).
    Montagnani M, Chen H, Barr VA, Quon MJ.
    J Biol Chem; 2001 Aug 10; 276(32):30392-8. PubMed ID: 11402048
    [Abstract] [Full Text] [Related]

  • 18. Involvement of STIM1 in the proteinase-activated receptor 1-mediated Ca2+ influx in vascular endothelial cells.
    Hirano K, Hirano M, Hanada A.
    J Cell Biochem; 2009 Oct 01; 108(2):499-507. PubMed ID: 19626660
    [Abstract] [Full Text] [Related]

  • 19. Activation of endothelial nitric oxide synthase by cilostazol via a cAMP/protein kinase A- and phosphatidylinositol 3-kinase/Akt-dependent mechanism.
    Hashimoto A, Miyakoda G, Hirose Y, Mori T.
    Atherosclerosis; 2006 Dec 01; 189(2):350-7. PubMed ID: 16545819
    [Abstract] [Full Text] [Related]

  • 20. Hepatocyte growth factor activates endothelial nitric oxide synthase by Ca(2+)- and phosphoinositide 3-kinase/Akt-dependent phosphorylation in aortic endothelial cells.
    Makondo K, Kimura K, Kitamura N, Kitamura T, Yamaji D, Jung BD, Saito M.
    Biochem J; 2003 Aug 15; 374(Pt 1):63-9. PubMed ID: 12757411
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.